Canada Judgment

Federal Court

Plante v. Entreprises Réal Caron ltée

On this page

Professional case brief

Research organized from the available case record

Source document

01

Holding and result

The motion to dismiss is dismissed because the requested interlocutory evaluation would improperly decide merits; striking is exceptional under Pharmacia and the respondent must raise evidentiary objections through Rules 307 and 310 at the appropriate stage, so the proceeding should continue with directed timelines (Applicant's Record to be filed by July 25, 2007).

Court disposition

Motion to dismiss denied; costs awarded in the cause; directions given to proceed with filing of records and normal timelines under the Federal Court Rules.

Orders

  • Motion to dismiss is dismissed, with costs in the cause.
  • The applicant shall serve and file his Applicant's Record under Rule 309 on or before July 25, 2007.
  • Thereafter, the normal timelines for Rule 310 et seq. shall apply.
  • The applicant must be particularly vigilant in respecting the timeline under paragraph 1 and the timeline set out in Rule 314.

02

Material facts

Parties

CLAUDE PLANTE

Applicant Counsel: Self-represented

LES ENTREPRISES RÉAL CARON LTÉE

Respondent Counsel: Guy Sirois

Amounts and remedies

  • Costs Awarded: 0

03

Procedural history

  1. Posture

    Judicial Review / Interlocutory Motion

04

Questions and positions

Legal issues

Party arguments

Applicant
Applicant sought judicial review of the adjudicator's January 15, 2007 decision, included exhibits and appendices in a Rule 306 affidavit which he says were mentioned and marked at the adjudicator's oral hearing, and opposed dismissal.
Respondent
Respondent argued the application is frivolous, abusive and a delaying tactic and sought dismissal of the application and of exhibits and appendices not filed as evidence before the adjudicator, urging the Court to apply the standard of review appropriate to strike at interlocutory stage.

05

Court’s reasoning

  1. 01

    Bull (David) Laboratories (Canada) Inc. v. Pharmacia Inc. (1994), 176 N.R. 48

    Striking an application for judicial review at the interlocutory stage must be exceptional to preserve the objective of advancing to a merits hearing promptly.

  2. 02

    Bull (David) Laboratories (Canada) Inc. v. Pharmacia Inc.; Federal Court inherent jurisdiction cited by Prothonotary

    The Court has inherent jurisdiction to manage proceedings, including striking, but should not routinely decide merits at interlocutory motions.

  3. 03

    Federal Court Rules (Rules 306, 307, 309, 310, 314) and Pharmacia guidance

    Objections to documents and evidence are properly raised in respondent affidavits and the Respondent Record under the Federal Court Rules (Rules 307 and 310) rather than by interlocutory striking.

06

Ratio, limits and disposition

Ratio decidendi

The motion to dismiss is dismissed because the requested interlocutory evaluation would improperly decide merits; striking is exceptional under Pharmacia and the respondent must raise evidentiary objections through Rules 307 and 310 at the appropriate stage, so the proceeding should continue with directed timelines (Applicant's Record to be filed by July 25, 2007).

Obiter and limits

  • The court invoked its inherent jurisdiction but declined to undertake the merits assessment sought by respondent.
  • The court referenced Merck Frosst and Glaxo Wellcome as supportive authorities for progressing to merits rather than interlocutory striking.
  • The court reminded the applicant to respect the timelines, including Rule 314, and warned that the respondent can properly identify circumstances surrounding disputed documents at Rule 310.

Court disposition

Motion to dismiss denied; costs awarded in the cause; directions given to proceed with filing of records and normal timelines under the Federal Court Rules.

  • Motion to dismiss is dismissed, with costs in the cause.
  • The applicant shall serve and file his Applicant's Record under Rule 309 on or before July 25, 2007.
  • Thereafter, the normal timelines for Rule 310 et seq. shall apply.
  • The applicant must be particularly vigilant in respecting the timeline under paragraph 1 and the timeline set out in Rule 314.

Source and reliance status

Federal Court · 12 July 2007

This page organises the available record for research. Confirm quotations, current status, and subsequent treatment against the official source before relying on the case.

Judgment reading view

Judgment text

The complete available source text.

Source document

Federal Court

Judgment· 12 July 2007

2007 FC 744

Plante v. Entreprises Réal Caron ltée Court (s) Database Federal Court Decisions Date 2007-07-12 Neutral citation 2007 FC 744 File numbers T-289-07 Decision Content Date: 20070712 Docket: T-289-07 Citation: 2007 FC 744 [ENGLISH TRANSLATION] Montréal, Quebec, July 12, 2007 PRESENT: Richard Morneau, Esq., Prothonotary BETWEEN:

CLAUDE PLANTE Applicant and LES ENTREPRISES RÉAL CARON LTÉE Respondent REASONS FOR ORDER AND ORDER [1] This is a motion by the respondent seeking the dismissal of the application for judicial review (the application) filed by the applicant — who is representing himself — on the grounds that the application is, upon review, frivolous, abusive, and a delaying tactic. [2] At the same time, the respondent is seeking the dismissal of exhibits and appendices that the applicant included with his affidavit under Rule 306 of the Federal Court Rules (the Rules), as those documents were allegedly not, as such, filed as evidence before the adjudicator whose decision dated January 15, 2007, is the subject of the application. Those documents, however, were apparently mentioned in the applicant’s oral arguments before that adjudicator and were apparently marked by that adjudicator. [3] Here, the respondent is essentially asking that, at the interlocutory stage, we somewhat literally hear the position that it plans to argue on merit against the application by inviting the Court to retain the standard of judicial review that it feels applies to this case and, based on the law and the comprehensiveness of the decision under review, assess the weakness of the position developed thus far by the applicant in his notice of application and the affidavit that he filed under Rule 306. [4] Although it

was not filed under that head, it seems to me that the motion under review must be addressed under the inherent jurisdiction of this court, as applied by Strayer J. in Bull (David) Laboratories (Canada) Inc. v. Pharmacia Inc. et al. (1994), 176 N.R. 48, at pages 53 to 55. [5] I feel that the exercise that the respondent is asking us to carry out in this motion exceeds here the type of exercise that Pharmacia sets forth for an application for judicial review. [6] Any application to strike as part of an application for judicial review must be exceptional, in order to promote one of the main objectives of such an application, that of hearing the application on merit as soon as possible. [7] As indicated by Strayer J. in Pharmacia, at page 53: … [T]he focus in judicial review is on moving the application along to the hearing stage as quickly as possible. This ensures that objections to the originating notice can be dealt with promptly in the context of consideration of the merits of the case. (See also Merck Frosst Canada Inc. et al. v. Minister of National Health and Welfare et al. (1994), 58 C.P.R. (3d) 245, at page 248, and Glaxo Wellcome Inc. et al. v. Minister of National Health and Welfare et al., unreported judgment by this Court, September 6, 1996, docket T-793-96.) [8] Under the circumstances, I do not feel that it is appropriate to embark on an evaluation that must be

conducted on merit. [9] I feel that the respondent should and must argue what it sought to argue here in its affidavit(s) under Rule 307 and its Respondent Record under Rule 310. The same is true for the documents that it seeks to strike from the applicant’s affidavit, as it is quite able to identify the circumstances surrounding those documents and that position can be well brought to the judge’s attention on time at the stage of Rule 310. [10] For these reasons, the respondent’s motion to dismiss shall be dismissed.

ORDER This motion to dismiss is dismissed, with costs in the cause. The subsequent timeline to be followed shall be: 1. The applicant shall serve and file his Applicant’s Record under Rule 309 on or before July 25, 2007; 2. Thereafter, the normal timelines for Rule 310 et seq. shall apply. The Court reminds the applicant here that he must be particularly vigilant in respecting the timeline under paragraph 1 above and the timeline set out in Rule 314. “Richard Morneau” Prothonotary

FEDERAL COURT

SOLICITORS OF RECORD DOCKET: T-289-07 STYLE OF CAUSE: CLAUDE PLANTE Applicant and LES ENTREPRISES RÉAL CARON LTÉE Respondent PLACE OF HEARING: Montréal, Quebec DATE OF HEARING: July 9, 2007 REASONS FOR ORDER: PROTHONOTARY MORNEAU DATED: July 12, 2007 APPEARANCES: (on his own behalf)

FOR THE APPLICANT Guy Sirois

FOR THE RESPONDENT SOLICITORS OF RECORD:

FOR THE APPLICANT Guy Sirois

FOR THE RESPONDENT

Source wording is retained. Consult the source document for its original formatting and pagination.

Authorities

Authorities used by the court

Cases, legislation, regulations, and constitutional provisions identified in the available record.

Bull (David) Laboratories (Canada) Inc. v. Pharmacia Inc. (1994), 176 N.R. 48

Case cited

Merck Frosst Canada Inc. v. Minister of National Health and Welfare (1994), 58 C.P.R. (3d) 245

Case cited

Glaxo Wellcome Inc. v. Minister of National Health and Welfare, unreported, September 6, 1996, docket T-793-96

Case cited

Federal Court Rules (Rules 306, 307, 309, 310, 314)

Legislation

Legislation referenced in the available case record.

Case-aware research

Ask AI about this case

The judgment and available research above are public. New questions open in a separate private conversation grounded in this case.

About this LexChat collection

This page organizes the available case record for research. Verify quotations, current status, and subsequent treatment against the source document. Corrections can be reported to hello@esheria.ai.

Legal information, not legal advice. Research summaries do not replace the judgment.